Is ATHA A Good Stock To Buy According To Hedge Funds?
A whopping number of 13F filings filed with U.S.
Athira Pharma Inc. (ATHA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 5,402,964 | $3,169,919 | 0.08% | |
| 2. | Propel Bio Management Leen Kawas And Richard Kayne | 1,492,792 | $875,821 | 0.86% | |
| 3. | Tang Capital Management Kevin C. Tang | 600,000 | $352,020 | 0.02% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 253,300 | $148,611 | -25% | 0% |
| 5. | Renaissance Technologies Jim Simons | 207,300 | $121,623 | -55% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.42 | 27,400 | 80,715 | 2024-06-24 | Filing | ||
| $2.26 | 15,000 | 53,315 | 2024-06-21 | Filing | ||
| $2.38 | 163,954 | Large Shareholder, Director | 5,402,964 | 2023-12-29 | Filing | |
| $2.44 | 409,598 | Large Shareholder, Director | 5,239,010 | 2023-12-28 | Filing | |
| $2.28 | 32,134 | Large Shareholder, Director | 4,829,412 | 2023-12-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.56 | 10,826 | 35,841 | 2025-01-02 | Filing | ||
| $0.56 | 25,107 | 242,591 | 2025-01-02 | Filing | ||
| $0.56 | 8,510 | 130,761 | 2025-01-02 | Filing | ||
| $0.56 | 2,881 | 89,724 | 2025-01-02 | Filing | ||
| $0.56 | 8,510 | 83,735 | 2025-01-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,775,885 | $1,628,612 | 1.01% | |
| 2. | 1,556,651 | $913,754 | 0% | |
| 3. | 1,492,792 | $875,821 | 0.04% | |
| 4. | 458,765 | $269,157 | 0% | |
| 5. | 416,143 | $243,859 | 0% |
News See All
Billionaire Hedge Funds
